Adopts the Interstate Compact to Phase Out Corporate Welfare.
Sponsored bills
Authorizes the Department of Health to implement a program to purchase prescription drugs for the county public employers, self-insured private employers, and health insurance carriers under the purchasing authority of the State.
Requires drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a sixteen per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame.
Appropriates funds for capital improvement projects in the thirty-fifth representative district.
By 1/1/2023, requires the department of labor and industrial relations to establish a family and medical leave insurance program and begin collecting payroll contributions to finance payment of benefits. By 1/1/2024, requires the department to start receiving claims and paying benefits under the program. Specifies eligibility requirements and employee protections under the program.
Increases the fines assessed against noncandidate committees for violations of organizational report requirements. Increases the fines for violations of campaign advertisement notice requirements. Effective 7/1/2112. (HD2)
Exempts income received from unemployment compensation benefits from state income tax. Effective 1/1/2021.
Imposes dollar limits on specialty tiers in order to protect patients from unaffordable coinsurance or copayment amounts. Limits patients' coinsurance or copayment fees for specialty tier drugs to $150 per month for up to a thirty-day period supply. Allow patients to request an exception to obtain a specialty drug that would not otherwise be available on a health plan formulary.
Temporarily halts nonjudicial foreclosures by condominium associations until 6/30/23.
Requires certain drug manufacturers to pay monetary penalties to the insurance commissioner for unsupported price increases on prescription drugs sold in the State. Provides for appeals and judicial review. Establishes the identified drug offset special fund. Requires annual reports to the legislature.